Valuation: Bure Equity AB

Market Cap 2.17TCr 218.84Cr 195.05Cr 179.5Cr 163.35Cr 306.65Cr 21TCr 312.07Cr 853.29Cr 11TCr 821.13Cr 803.79Cr 35TCr P/E 2024
4.94x
P/E 2025 -3.91x
Enterprise Value 2.13TCr 215.42Cr 192Cr 176.69Cr 160.8Cr 301.86Cr 20TCr 307.19Cr 839.95Cr 11TCr 808.29Cr 791.22Cr 34TCr EV / Sales 2024
4.74x
EV / Sales 2025 -3.91x
Free-Float
70.39%
Yield 2024
0.72%
Yield 2025 1.11%
1 day-0.34%
1 week-7.22%
Current month-8.04%
1 month-8.68%
3 months+9.01%
6 months+9.75%
Current year+17.67%
1 week 286.4
Extreme 286.4
300
1 month 286.4
Extreme 286.4
325
Current year 190.2
Extreme 190.2
330.6
1 year 190.2
Extreme 190.2
330.6
3 years 190.2
Extreme 190.2
421.2
5 years 171.3
Extreme 171.3
474.6
10 years 86.8
Extreme 86.8
489.2
Manager TitleAgeSince
Chief Executive Officer 55 22/04/2013
Director of Finance/CFO 58 01/10/2013
Chief Investment Officer 46 01/01/2019
Director TitleAgeSince
Director/Board Member 56 30/04/2010
Chairman 62 22/04/2013
Director/Board Member 60 04/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
21/08/26 Buy

Director

1,100 0.0015%
01/06/26 Buy

Chief Financial Officer

1,069 0.0014%
26/05/26 Buy 67,000 0.0904%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-7.22%+3.64%+34.82% 219.9Cr
-1.80%-1.54%+30.26%+103.38% 13TCr
-2.04%-2.04%+28.63%+80.89% 2.25TCr
-0.73%-0.37%+20.35%+53.96% 1.67TCr
+0.08%-0.31%+12.10%+160.68% 1.58TCr
-1.66%-1.31%+10.06%+27.63% 1.44TCr
-0.29%+0.78%-12.77%+11.40% 1.35TCr
+2.79%+3.80%-11.62%+59.42% 1.29TCr
-4.26%-8.92%+56.57%+73.57% 1.25TCr
+1.59%+1.39%+23.72%+36.33% 1.23TCr
Average -0.67%-0.87%+16.10%+64.21% 2.51TCr
Weighted average by Cap. -1.25%-0.00%+23.47%+84.83%

Financials

2024 2025
Net sales 580.7Cr 59Cr 52Cr 48Cr 44Cr 82Cr 5.56TCr 84Cr 228.58Cr 2.92TCr 219.97Cr 215.32Cr 9.26TCr -460.1Cr -46Cr -41Cr -38Cr -35Cr -65Cr -4.4TCr -66Cr -181.11Cr -2.31TCr -174.28Cr -170.6Cr -7.34TCr
Net income 574.2Cr 58Cr 52Cr 48Cr 43Cr 81Cr 5.5TCr 83Cr 226.03Cr 2.88TCr 217.51Cr 212.91Cr 9.16TCr -467.8Cr -47Cr -42Cr -39Cr -35Cr -66Cr -4.48TCr -67Cr -184.14Cr -2.35TCr -177.2Cr -173.46Cr -7.46TCr
Net Debt -78Cr -7.86Cr -7.01Cr -6.45Cr -5.87Cr -11Cr -745.68Cr -11Cr -31Cr -391.4Cr -30Cr -29Cr -1.24TCr -34Cr -3.42Cr -3.05Cr -2.81Cr -2.55Cr -4.8Cr -324.5Cr -4.88Cr -13Cr -170.33Cr -13Cr -13Cr -540.58Cr
Projected Income Statement - Annual - Bure Equity AB
Logo Bure Equity AB
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Employees
12
Date Price Change Volume
22/26/22 SEK 290.40 -0.34% 84,354
21/26/21 SEK 291.40 +0.28% 99,026
20/26/20 SEK 290.60 -0.82% 66,744
19/26/19 SEK 293.00 -0.20% 73,948
16/26/16 SEK 293.60 -1.01% 1,05,212
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. BURE Stock